Breaking News

Lonza & Oxford Nanopore Partner to Develop Nanopore Sequencing Test for mRNA Products

Aim to address the industry and regulatory need for a cGMP-grade common testing method to simplify and streamline mRNA manufacturing.

Author Image

By: Charlie Sternberg

Associate Editor

Lonza, a global development and manufacturing partner, has entered a collaboration with Oxford Nanopore Technologies plc, a company delivering a new generation of nanopore-based molecular sensing technology, in order to cGMP validate and commercialize a first-of-its-kind novel test to accurately determine multiple critical quality attributes of mRNA products by directly sequencing both the DNA template and the messenger RNA (mRNA).   mRNA products can be designed, manufactured, and brought to ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters